Propentofylline (HWA 285) is a xanthine derivative drug with purported neuroprotective effects.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.133.568 |
Chemical and physical data | |
Formula | C15H22N4O3 |
Molar mass | 306.366 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |
It is a phosphodiesterase inhibitor,[1] and also acts as an adenosine reuptake inhibitor.[1][2][3]
Propentofylline was studied as a possible treatment for Alzheimer's disease and multi-infarct dementia,[1][4] and has been studied, to a lesser extent, as a possible adjunct in the treatment of ischemic stroke, due to its vasodilating properties.[5][6]
Propentofylline is in use as a veterinary medicine in older dogs.[7]